Sphingolipid Analysis Indicate Lactosylceramide as a Potential Biomarker of Inflammatory Bowel Disease in Children

Metabolomic profiling in children with inflammatory bowel disease

(2020) Aleksandra Filimoniuk et al.   Advances in Medical Sciences

Untargeted Metabolomics and Inflammatory Markers Profiling in Children With Crohn’s Disease and Ulcerative Colitis—A Preliminary Study

(2019) Urszula Daniluk et al.   INFLAMMATORY BOWEL DISEASES

Lipidomics in Ulcerative Colitis Reveal Alteration in Mucosal Lipid Composition Associated With the Disease State

(2019) Joseph Diab et al.   INFLAMMATORY BOWEL DISEASES

The Lipid Status in Patients with Ulcerative Colitis: Sphingolipids are Disease-Dependent Regulated

(2019) Sarah Bazarganipour et al.   Journal of Clinical Medicine

Lactosylceramide synthase β-1,4-GalT-V: A novel target for the diagnosis and therapy of human colorectal cancer

(2018) Subroto B. Chatterjee et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

The combination of fecal calprotectin with ESR, CRP and albumin discriminates more accurately children with Crohn’s disease

(2018) Urszula Daniluk et al.   Advances in Medical Sciences

The ESPGHAN Revised Porto Criteria for the Diagnosis of Inflammatory Bowel Disease in Children and Adolescents

(2013) Arie Levine et al.   JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION

The Yin and Yang of lactosylceramide metabolism: Implications in cell function

(2007) Subroto Chatterjee et al.   BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS